Imagen de Portada

Safety and feasibility analysis of rapid daratumumab infusion in Chinese patients with multiple myeloma

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Xi‐xi Yin, Yueyun Hu, Yusi Yang, Xinglan Zhang, Li Liu, Xi Cao, Jianwen Chen, Zhongjun Xia, Ye Wang
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Cancer Medicine
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab‐based regimens
por: Danilo De Novellis, et al.
Publicado: (2024)

Clinical outcomes of pomalidomide‐based and daratumumab‐based therapies in patients with relapsed/refractory multiple myeloma: A real‐world cohort study in China
por: Xiaoyan Han, et al.
Publicado: (2024)

Angiogenesis and multiple myeloma: Exploring prognostic potential of adrenomedullin
por: Angelos Giannakoulas, et al.
Publicado: (2024)

Infections associated with CAR ‐T cell therapy in patients with relapsed refractory multiple myeloma: Risks and prevention strategies
por: Jing An, et al.
Publicado: (2024)

“They don't care to study it”: Trust, race, and health care experiences among patient‐caregiver dyads with multiple myeloma
por: Shakira J. Grant, et al.
Publicado: (2024)

The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation
por: Yutaka Shimazu, et al.
Publicado: (2024)

miR‐34a promotes the immunosuppressive function of multiple myeloma‐associated macrophages by dampening the TLR‐9 signaling
por: Rui Zhang, et al.
Publicado: (2024)

A real‐world retrospective–prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience
por: Anna Furlan, et al.
Publicado: (2024)

Impact of M‐protein detection on the response evaluations of patients undergoing treatment with the IgG‐κ monoclonal antibodies daratumumab or isatuximab, and discrepancies between immunofixation electrophoresis (IFE) systems and reagents
por: Yuko Shirouchi, et al.
Publicado: (2024)

Predictive factors for peripheral blood stem cell mobilization in multiple myeloma in the era of novel therapies: A single‐center experience
por: Xiao He, et al.
Publicado: (2024)

The quantitative parameters based on marrow metabolism derived from synthetic MRI: A pilot study of prognostic value in participants with newly diagnosed multiple myeloma
por: Sha Cui, et al.
Publicado: (2024)

Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre‐transplant minimal residual disease on outcomes in high‐risk acute lymphoblastic leukemia patients in complete remission
por: Xiaoyan Zhao, et al.
Publicado: (2024)

Genomic heterogeneity of multiple synchronous lung cancers in Chinese population
por: Lei Zhao, et al.
Publicado: (2024)

Advancing Tumor Budding Detection With Fourier Ptychography Microscopy
por: Yiyan Su, et al.
Publicado: (2025)

Survival and safety analysis of COVID‐19 vaccine in Chinese patients with non‐small cell lung cancer
por: Wei Xu, et al.
Publicado: (2024)

A predictive risk‐scoring model for survival prognosis of multiple myeloma based on gain/amplification of 1q21: Experience in a tertiary hospital in South‐Western China
por: Yanqiu Xiong, et al.
Publicado: (2024)

Assessment value of interleukin‐6, procalcitonin, and C‐reactive protein early kinetics for initial antibiotic efficacy in patients with febrile neutropenia: A prospective study
por: Haifeng Zheng, et al.
Publicado: (2024)

Causal associations between atrial fibrillation and breast cancer: A bidirectional Mendelian randomization analysis
por: Zhaoting Gong, et al.
Publicado: (2024)

Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes
por: Lan Chen, et al.
Publicado: (2024)

Adjuvant 5‐fluorouracil and portal vein infusion chemotherapy followed by gemcitabine for pancreatic cancer
por: Minoru Kitago, et al.
Publicado: (2024)

Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein‐1 inhibitors: A promising treatment approach for high‐burden hepatocellular carcinoma
por: Shumin Fu, et al.
Publicado: (2024)

Safety and efficacy of fruquintinib‐based therapy in patients with advanced or metastatic sarcoma
por: Chenliang Zhou, et al.
Publicado: (2024)

Cell fusion between tumor cells and macrophages promotes the metastasis of OSCC patient through the activation of the chemokine signaling pathway
por: Chengwan Xia, et al.
Publicado: (2024)

Distinct Clinicopathological Features of HER2 ‐Negative, HER2 ‐Low, and HER2 ‐Overexpressing Urothelial Carcinoma in a Large Chinese Cohort
por: Shanshan Wang, et al.
Publicado: (2025)

Relationship between educational level and survival of patients with cancer: A multicentre cohort study
por: Xiao‐Yue Liu, et al.
Publicado: (2024)

Biomarkers of peripheral blood neutrophil extracellular traps in the diagnosis and progression of malignant tumors
por: Min Wang, et al.
Publicado: (2024)

Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study
por: Chao An, et al.
Publicado: (2024)

Efficacy and Safety of Multivisceral Resection for Ovarian Cancer: A Comparative Study of Gynecologic Oncologists and Multidisciplinary Surgeons
por: Luxin Ye, et al.
Publicado: (2026)

Cost‐effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR‐mutated advanced non‐small cell lung cancer
por: Wentao Tian, et al.
Publicado: (2024)

Safety, Pharmacokinetics, and Pharmacodynamics Evaluation of Ivonescimab, a Novel Bispecific Antibody Targeting PD‐1 and VEGF, in Chinese Patients With Advanced Solid Tumors
por: Fenghua Wang, et al.
Publicado: (2025)

Gut microbial subtypes and clinicopathological value for colorectal cancer
por: Shuwen Han, et al.
Publicado: (2024)

SPARC Promotes Aerobic Glycolysis and 5‐Fluorouracil Resistance in Colorectal Cancer Through the STAT3/HK2 Axis
por: Jingrong Xiang, et al.
Publicado: (2025)

Application of GPRC5D Targeting Therapy in Relapsed Refractory Multiple Myeloma
por: Sijia Yan, et al.
Publicado: (2025)

The feasibility and acceptability of collecting psychosocial outcome measures embedded within a precision medicine trial for childhood cancer
por: Eden G. Robertson, et al.
Publicado: (2024)

Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High‐Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Insights From a Multicenter Study
por: Dong Liang, et al.
Publicado: (2024)

Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With EGFR Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers
por: Jinjing Tan, et al.
Publicado: (2025)

A polygenetic risk score combined with environmental factors better predict susceptibility to hepatocellular carcinoma in Chinese population
por: Yuanlin Zou, et al.
Publicado: (2024)

The inverted U‐shaped relationship between epinephrine and pancreatic ductal adenocarcinoma patients' survival with compensation of lymphocyte
por: Bing‐Xue Li, et al.
Publicado: (2024)

Somatic mutations in a multigene panel and impact on prognosis based on TP53 status in Chinese HER2‐positive patients undergoing neoadjuvant therapy: A single‐institution retrospective cohort
por: Min Xiong, et al.
Publicado: (2024)

Comparison of SOX and CAPOX in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: A randomized controlled trial
por: Xin Liu, et al.
Publicado: (2024)